Small vessel disease: mechanisms and clinical implications

JM Wardlaw, C Smith, M Dichgans - The Lancet Neurology, 2019 - thelancet.com
Small vessel disease is a disorder of cerebral microvessels that causes white matter
hyperintensities and several other common abnormalities (eg, recent small subcortical infarcts and …

Perivascular spaces in the brain: anatomy, physiology and pathology

JM Wardlaw, H Benveniste, M Nedergaard… - Nature Reviews …, 2020 - nature.com
Perivascular spaces include a variety of passageways around arterioles, capillaries and
venules in the brain, along which a range of substances can move. Although perivascular …

Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration

JM Wardlaw, EE Smith, GJ Biessels… - The Lancet …, 2013 - thelancet.com
Cerebral small vessel disease (SVD) is a common accompaniment of ageing. Features
seen on neuroimaging include recent small subcortical infarcts, lacunes, white matter …

Thrombolysis for acute ischaemic stroke

JM Wardlaw, V Murray, E Berge… - Cochrane database of …, 2014 - cochranelibrary.com
Background Most strokes are due to blockage of an artery in the brain by a blood clot. Prompt
treatment with thrombolytic drugs can restore blood flow before major brain damage has …

Mechanisms of sporadic cerebral small vessel disease: insights from neuroimaging

JM Wardlaw, C Smith, M Dichgans - The Lancet Neurology, 2013 - thelancet.com
The term cerebral small vessel disease (SVD) describes a range of neuroimaging, pathological,
and associated clinical features. Clinical features range from none, to discrete focal …

Recommendations on angiographic revascularization grading standards for acute ischemic stroke: a consensus statement

…, DF Kallmes, BFM Fitzsimmons, J Mocco, JM Wardlaw… - Stroke, 2013 - Am Heart Assoc
Methods A hybrid approach based on established processes described by Glaser15 and by
the National Institutes of Health (http://prevention. nih. gov/cdp/about. aspx) 16 was used to …

[HTML][HTML] Recombinant tissue plasminogen activator for acute ischaemic stroke: an updated systematic review and meta-analysis

JM Wardlaw, V Murray, E Berge, G Del Zoppo… - The Lancet, 2012 - thelancet.com
Background Recombinant tissue plasminogen activator (rt-PA, alteplase) improved functional
outcome in patients treated soon after acute ischaemic stroke in randomised trials, but …

Blood–brain barrier: ageing and microvascular disease–systematic review and meta-analysis

AJ Farrall, JM Wardlaw - Neurobiology of aging, 2009 - Elsevier
Cerebral “microvascular” disease occurs in lacunar stroke, leukoaraiosis, vascular dementia
and Alzheimer's disease. It may arise from or contribute to insidious damage to the blood–…

Stroke subtype, vascular risk factors, and total MRI brain small-vessel disease burden

…, SDJ Makin, FN Doubal, MS Dennis, JM Wardlaw - Neurology, 2014 - AAN Enterprises
Objectives: In this cross-sectional study, we tested the construct validity of a “total SVD score,”
which combines individual MRI features of small-vessel disease (SVD) in one measure, by …

What are white matter hyperintensities made of? Relevance to vascular cognitive impairment

JM Wardlaw, MC Valdés Hernández… - Journal of the …, 2015 - Am Heart Assoc
White matter hyperintensities (WMH) of presumed vascular origin, also referred to as leukoaraiosis,
are a very common finding on brain magnetic resonance imaging (MRI) or computed …